On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Hospital General de México

InstitutionResearch output, impact & collaborations

Hospital General de México is a institution indexed in ScholarIQ from OpenAlex.

What is known about Hospital General de México?

ScholarIQrecord summary

Hospital General de México is a research organisation in Mexico City, MX. OpenAlex records 8,815 works and 254,546 citations for it. 5,342 researchers list it as their most recent affiliation.

How many works does Hospital General de México have?

ScholarIQindexed works

Hospital General de México has 8,815 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Hospital General de México have?

ScholarIQcitation count

Hospital General de México has 254,546 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Hospital General de México?

ScholarIQresearcher count

Hospital General de México has 5,342 researchers in the ScholarIQ index.

What is the average h-index at Hospital General de México?

ScholarIQavg h-index

Hospital General de México has an average h-index of 61 in OpenAlex.

What is the ROR of Hospital General de México?

ScholarIQror

The ROR for Hospital General de México is on the source record.

What is the OpenAlex record for Hospital General de México?

ScholarIQopenalex

The OpenAlex for Hospital General de México is on the source record.

What is the Wikidata of Hospital General de México?

ScholarIQwikidata

The Wikidata for Hospital General de México is on the source record.

Who are the most-cited researchers behind Hospital General de México?

ScholarIQtop researchers by citations
1
Rubén Burgos‐Vargas · Spondyloarthritis Studies and Treatments
324 works20,325 citations

What are the most-cited papers on Hospital General de México?

ScholarIQmost cited works
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
Claire Bombardier, Loren Laine, Alise Reicin, Deborah R. Shapiro, Rubén Burgos‐Vargas, Barry R. Davis, Richard O. Day, Marcos Bosi Ferraz, Christopher J. Hawkey, Marc C. Hochberg, Tore K Kvien, Thomas J. Schnitzer
New England Journal of Medicine. 20004,044 CitationsOPEN ACCESS
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo
Joel M. Kremer, Bradley J. Bloom, Ferdinand C. Breedveld, John Coombs, Mark P. Fletcher, David Gruben, Sriram Krishnaswami, Rubén Burgos‐Vargas, Bethanie Wilkinson, Cristiano A. F. Zerbini, Samuel H. Zwillich
Arthritis & Rheumatism. 2009545 Citations
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Rubén Burgos‐Vargas, Anne-Marie Halland, Emma Vernon, Petra Ambs, Roy Fleischmann
Arthritis & Rheumatism. 2010414 Citations

How much of the research on Hospital General de México is open access?

ScholarIQopen access share
33%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
33%
Closed
67%

Related on ScholarIQ

470M+ articles · 14-day free trial